Yunfei Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 5
- Peptidase Inhibition and Analysis 5
- Molecular Biology top 10%
- Fibroblast Growth Factor Research 6
- Protein Tyrosine Phosphatases 6
- RNA modifications and cancer 5
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 25
-
- Gastric Cancer Management and Outcomes 4
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yunfei Xu
83 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 432
- Oncology 484
- Molecular Biology 1.1k
- Immunology 195
- Surgery 374
Countries citing papers authored by Yunfei Xu
This map shows the geographic impact of Yunfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Xu more than expected).
Fields of papers citing papers by Yunfei Xu
This network shows the impact of papers produced by Yunfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Xu. The network helps show where Yunfei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yunfei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 18 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 19 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 27 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 9 | |
| 16 | 2019 | 10 | |
| 17 | 2018 | 64 | |
| 18 | 2015 | 2 | |
| 19 | 2014 | 67 | |
| 20 | 2013 | 3 |
About Yunfei Xu
Yunfei Xu is a scholar working on Energy Engineering and Power Technology, Family Practice and Oncology, having authored 98 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Fibroblast Growth Factor Research (6 papers), Protein Tyrosine Phosphatases (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (5 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Cancer Research (432 citations), Oncology (484 citations) and Molecular Biology (1.1k citations). Yunfei Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zongli Zhang, Hongda Liu, Kangshuai Li, Zengli Liu, Shanglei Ning, Tianli Chen, Yuxin Chen, Zheng Gong, Xiaoqing Yang and Rongqi Sun. Their work appears in journals such as Nature, Journal of Clinical Oncology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.